- Home
- YPF vs ROIV Comparison
YPF vs ROIV Comparison
Compare YPF & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YPF
- ROIV
- Stock Information
- Founded
- YPF 1977
- ROIV 2014
- Country
- YPF Argentina
- ROIV United Kingdom
- Employees
- YPF N/A
- ROIV N/A
- Industry
- YPF Integrated oil Companies
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- YPF Energy
- ROIV Health Care
- Exchange
- YPF Nasdaq
- ROIV Nasdaq
- Market Cap
- YPF 8.5B
- ROIV 8.4B
- IPO Year
- YPF 1993
- ROIV N/A
- Fundamental
- Price
- YPF $22.73
- ROIV $12.19
- Analyst Decision
- YPF Buy
- ROIV Strong Buy
- Analyst Count
- YPF 6
- ROIV 10
- Target Price
- YPF $24.77
- ROIV $17.33
- AVG Volume (30 Days)
- YPF 1.7M
- ROIV 4.7M
- Earning Date
- YPF 08-09-2024
- ROIV 08-08-2024
- Dividend Yield
- YPF N/A
- ROIV N/A
- EPS Growth
- YPF N/A
- ROIV N/A
- EPS
- YPF N/A
- ROIV 5.65
- Revenue
- YPF $12,740,742,293.00
- ROIV $158,303,000.00
- Revenue This Year
- YPF $225.73
- ROIV $45.51
- Revenue Next Year
- YPF $3.03
- ROIV $37.40
- P/E Ratio
- YPF N/A
- ROIV $2.16
- Revenue Growth
- YPF 243.15
- ROIV 101.44
- 52 Week Low
- YPF $9.57
- ROIV $8.25
- 52 Week High
- YPF $24.77
- ROIV $13.24
- Technical
- Relative Strength Index (RSI)
- YPF 56.93
- ROIV 60.45
- Support Level
- YPF $23.11
- ROIV $11.50
- Resistance Level
- YPF $24.64
- ROIV $13.06
- Average True Range (ATR)
- YPF 0.80
- ROIV 0.40
- MACD
- YPF 0.08
- ROIV 0.03
- Stochastic Oscillator
- YPF 54.74
- ROIV 46.11
About YPF YPF Sociedad Anonima
YPF SA is an Argentina-based integrated oil and gas company. It is engaged in operating a fully integrated oil and gas chain across the domestic upstream, downstream, and gas and power segments. The company's upstream operations consist of the exploration, development, and production of crude oil, natural gas, and LPG. Its downstream operations include the refining, marketing, transportation, and distribution of oil and a wide range of petroleum products, petroleum derivatives, petrochemicals, LPG, and bio-fuels. The company generates maximum revenue from the downstream segment.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.